APTX - アプティニクス （Aptinyx Inc.） アプティニクスAPTXのチャート
APTXの企業情報
| symbol | APTx |
|---|---|
| 会社名 | Aptinyx Inc （アプティニクス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | 医薬品 医療関連（Health Care） |
| 概要 | 事業概要 Aptinyx Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops therapies for disorders of the brain and nervous system. The Company has a platform for discovering compounds that work through a mechanism which includes modulation of the N-methyl-D-aspartate (NMDA) receptor to develop pathways involved with nerve cell communication. The Company's compounds are effective on disease models including depression neuropathic pain migraine traumatic brain injury and age-induced learning impairment. The Company's compounds facilitate receptor activation without over-activating the receptor. The Company’s lead product candidate is NYX-2925 a treatment for the painful diabetic peripheral neuropathy. It is also developing NYX-783 for the treatment of post-traumatic stress disorder and NYX-458 for Parkinson’s disease cognitive impairment. The Company in partnership with Allergan plc develops AGN-241751 for major depressive disorder indications. アプティニクスは米国のバイオ医薬品企業。臨床段階で、脳や神経系疾患の治療に対する新規かつ独自の合成小分子の開発・商業化に従事する。同社パイプラインには、糖尿病による末梢神経障害や線維筋痛向けのNYX-2925、外傷後ストレス障害向けのNYX-783、パ―キンソン病認識機能障害向けのNYX-458を含む。本社所在地はイリノイ州エバンストン。 welcome to our company page and thank you for your interest in aptinyx inc. aptinyx is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the nmda receptor to enhance pathways involved with nerve cell communication. our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need. at aptinyx, we remain committed and responsive to our employees. we offer an engaging work environment, challenging work assignments, and competitive compensation and benefits. if you are interested in learning more, please visit our website at www.aptinyx.com. |
| 本社所在地 | 909 Davis Street Suite 600 Evanston IL 60201 USA |
| 代表者氏名 | Norbert G. Riedel ノーベルト・G・リーデル |
| 代表者役職名 | President Chief Executive Officer Director 社長兼最高経営責任者（CEO） |
| 電話番号 | +1 847-871-0377 |
| 設立年月日 | 42156 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2018年 |
| 従業員数 | － |
| url | www.aptinyx.com |
| nasdaq_url | https://www.nasdaq.com/symbol/aptx |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -40.34500 |
| 終値（lastsale） | 26.41 |
| 時価総額（marketcap） | 884635275.84 |
| 時価総額 | 時価総額（百万ドル） 917.46160 |
| 売上高 | 売上高（百万ドル） 6.98100 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 738.37160 |
| 当期純利益 | 当期純利益（百万ドル） -40.37900 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Aptinyx Inc revenues increased 78% to $4.6M. Net loss increased 50% to $25M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development increase of 53% to $25.5M (expense) General and administrative increase of 43% to $3.2M (expense). |
APTXのテクニカル分析
APTXのニュース
Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket 2023/03/24 12:21:34 Benzinga
Gainers Bird Global, Inc. (NYSE: BRDS ) shares rose 58.7% to $0.2250 in pre-market trading after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this spring. Dermata Therapeutics, Inc. (NASDAQ: DRMA ) gained 24.3% to $2.09 in pre-market trading after jumping 25% on Thursday. Maxim Group maintained Dermata Therapeutics with a Buy and lowered the price target from $16 to $4. Siyata Mobile Inc. (NASDAQ: SYTA ) gained 23.8% to $0.2097 in pre-market trading. Clean Energy Technologies, Inc. (NASDAQ: CETY ) climbed 22.8% to $4.88 in pre-market trading. Clean Energy Technologies reported the pricing of its underwritten public offering of 975,000 shares of common stock at $4.00 per share. Troika Media Group, Inc. (NASDAQ: TRKA ) rose 19.6% to $0.2136 in pre-market. Aptinyx Inc. (NASDAQ: APTX ) shares rose 18.3% to $0.2110 in pre-market trading. Aptinyx was granted European patent titled ''Spiro-lactam Nmda Receptor Modulators And Uses Thereof (for The Treatment Of Conditions Such As Depression And Related Disorders).'' Disc Medicine Opco Inc (NASDAQ: …
Is the Aptinyx Inc. (NASDAQ:APTX) stock an investment opportunity? 2023/03/20 17:16:00 US Post News
In the current trading session, Aptinyx Inc.’s (APTX) stock is trading at the price of $0.13, a fall of -4.40% over last night’s close. So, the stock is trading at a price that is -95.88% less than its 52-week high of $3.17 and 2.76% better than its 52-week low of $0.13. Based on the past […]
Is Aptinyx Inc. (NASDAQ:APTX) stock a better investment at this time? 2023/03/13 16:32:00 US Post News
Currently, Aptinyx Inc.’s (APTX) stock is trading at $0.14, marking a fall of -7.68% from last night’s close. At this price, the stock is -95.49% below its 52-week high of $3.17 and 3.92% above its 52-week low of $0.14. Based on the past 30-day period, the stock price is -76.76% below the high and +4.72% […]
Aptinyx Inc. (NASDAQ: APTX) Stock Forecast For 2023: $1.00 Per Share On The Upside 2023/03/13 12:30:00 Marketing Sentinel
In the last trading session, 4.04 million Aptinyx Inc. (NASDAQ:APTX) shares changed hands as the company’s beta touched 1.41. With the company’s per share price at $0.15 changed hands at $0.0 or 3.40% during last session, the market valuation stood at $10.09M. APTX’s last price was a discount, traded about -2013.33% off its 52-week high … Aptinyx Inc. (NASDAQ: APTX) Stock Forecast For 2023: $1.00 Per Share On The Upside Read More »
Aptinyx Inc. (NASDAQ:APTX) Shares Plunges -20.41% In A Week – But Can It Keep Rising? 2023/03/09 12:00:00 Marketing Sentinel
In last trading session, Aptinyx Inc. (NASDAQ:APTX) saw 9.1 million shares changing hands with its beta currently measuring 1.39. Company’s recent per share price level of $0.16 trading at -$0.02 or -13.81% at ring of the bell on the day assigns it a market valuation of $11.13M. That closing price of APTX’s stock is at … Aptinyx Inc. (NASDAQ:APTX) Shares Plunges -20.41% In A Week – But Can It Keep Rising? Read More »
Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket 2023/03/24 12:21:34 Benzinga
Gainers Bird Global, Inc. (NYSE: BRDS ) shares rose 58.7% to $0.2250 in pre-market trading after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this spring. Dermata Therapeutics, Inc. (NASDAQ: DRMA ) gained 24.3% to $2.09 in pre-market trading after jumping 25% on Thursday. Maxim Group maintained Dermata Therapeutics with a Buy and lowered the price target from $16 to $4. Siyata Mobile Inc. (NASDAQ: SYTA ) gained 23.8% to $0.2097 in pre-market trading. Clean Energy Technologies, Inc. (NASDAQ: CETY ) climbed 22.8% to $4.88 in pre-market trading. Clean Energy Technologies reported the pricing of its underwritten public offering of 975,000 shares of common stock at $4.00 per share. Troika Media Group, Inc. (NASDAQ: TRKA ) rose 19.6% to $0.2136 in pre-market. Aptinyx Inc. (NASDAQ: APTX ) shares rose 18.3% to $0.2110 in pre-market trading. Aptinyx was granted European patent titled ''Spiro-lactam Nmda Receptor Modulators And Uses Thereof (for The Treatment Of Conditions Such As Depression And Related Disorders).'' Disc Medicine Opco Inc (NASDAQ: …
Is the Aptinyx Inc. (NASDAQ:APTX) stock an investment opportunity? 2023/03/20 17:16:00 US Post News
In the current trading session, Aptinyx Inc.’s (APTX) stock is trading at the price of $0.13, a fall of -4.40% over last night’s close. So, the stock is trading at a price that is -95.88% less than its 52-week high of $3.17 and 2.76% better than its 52-week low of $0.13. Based on the past […]
Is Aptinyx Inc. (NASDAQ:APTX) stock a better investment at this time? 2023/03/13 16:32:00 US Post News
Currently, Aptinyx Inc.’s (APTX) stock is trading at $0.14, marking a fall of -7.68% from last night’s close. At this price, the stock is -95.49% below its 52-week high of $3.17 and 3.92% above its 52-week low of $0.14. Based on the past 30-day period, the stock price is -76.76% below the high and +4.72% […]
Aptinyx Inc. (NASDAQ: APTX) Stock Forecast For 2023: $1.00 Per Share On The Upside 2023/03/13 12:30:00 Marketing Sentinel
In the last trading session, 4.04 million Aptinyx Inc. (NASDAQ:APTX) shares changed hands as the company’s beta touched 1.41. With the company’s per share price at $0.15 changed hands at $0.0 or 3.40% during last session, the market valuation stood at $10.09M. APTX’s last price was a discount, traded about -2013.33% off its 52-week high … Aptinyx Inc. (NASDAQ: APTX) Stock Forecast For 2023: $1.00 Per Share On The Upside Read More »
Aptinyx Inc. (NASDAQ:APTX) Shares Plunges -20.41% In A Week – But Can It Keep Rising? 2023/03/09 12:00:00 Marketing Sentinel
In last trading session, Aptinyx Inc. (NASDAQ:APTX) saw 9.1 million shares changing hands with its beta currently measuring 1.39. Company’s recent per share price level of $0.16 trading at -$0.02 or -13.81% at ring of the bell on the day assigns it a market valuation of $11.13M. That closing price of APTX’s stock is at … Aptinyx Inc. (NASDAQ:APTX) Shares Plunges -20.41% In A Week – But Can It Keep Rising? Read More »
Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket 2023/03/24 12:21:34 Benzinga
Gainers Bird Global, Inc. (NYSE: BRDS ) shares rose 58.7% to $0.2250 in pre-market trading after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this spring. Dermata Therapeutics, Inc. (NASDAQ: DRMA ) gained 24.3% to $2.09 in pre-market trading after jumping 25% on Thursday. Maxim Group maintained Dermata Therapeutics with a Buy and lowered the price target from $16 to $4. Siyata Mobile Inc. (NASDAQ: SYTA ) gained 23.8% to $0.2097 in pre-market trading. Clean Energy Technologies, Inc. (NASDAQ: CETY ) climbed 22.8% to $4.88 in pre-market trading. Clean Energy Technologies reported the pricing of its underwritten public offering of 975,000 shares of common stock at $4.00 per share. Troika Media Group, Inc. (NASDAQ: TRKA ) rose 19.6% to $0.2136 in pre-market. Aptinyx Inc. (NASDAQ: APTX ) shares rose 18.3% to $0.2110 in pre-market trading. Aptinyx was granted European patent titled ''Spiro-lactam Nmda Receptor Modulators And Uses Thereof (for The Treatment Of Conditions Such As Depression And Related Disorders).'' Disc Medicine Opco Inc (NASDAQ: …
Is the Aptinyx Inc. (NASDAQ:APTX) stock an investment opportunity? 2023/03/20 17:16:00 US Post News
In the current trading session, Aptinyx Inc.’s (APTX) stock is trading at the price of $0.13, a fall of -4.40% over last night’s close. So, the stock is trading at a price that is -95.88% less than its 52-week high of $3.17 and 2.76% better than its 52-week low of $0.13. Based on the past […]
Is Aptinyx Inc. (NASDAQ:APTX) stock a better investment at this time? 2023/03/13 16:32:00 US Post News
Currently, Aptinyx Inc.’s (APTX) stock is trading at $0.14, marking a fall of -7.68% from last night’s close. At this price, the stock is -95.49% below its 52-week high of $3.17 and 3.92% above its 52-week low of $0.14. Based on the past 30-day period, the stock price is -76.76% below the high and +4.72% […]
Aptinyx Inc. (NASDAQ: APTX) Stock Forecast For 2023: $1.00 Per Share On The Upside 2023/03/13 12:30:00 Marketing Sentinel
In the last trading session, 4.04 million Aptinyx Inc. (NASDAQ:APTX) shares changed hands as the company’s beta touched 1.41. With the company’s per share price at $0.15 changed hands at $0.0 or 3.40% during last session, the market valuation stood at $10.09M. APTX’s last price was a discount, traded about -2013.33% off its 52-week high … Aptinyx Inc. (NASDAQ: APTX) Stock Forecast For 2023: $1.00 Per Share On The Upside Read More »
Aptinyx Inc. (NASDAQ:APTX) Shares Plunges -20.41% In A Week – But Can It Keep Rising? 2023/03/09 12:00:00 Marketing Sentinel
In last trading session, Aptinyx Inc. (NASDAQ:APTX) saw 9.1 million shares changing hands with its beta currently measuring 1.39. Company’s recent per share price level of $0.16 trading at -$0.02 or -13.81% at ring of the bell on the day assigns it a market valuation of $11.13M. That closing price of APTX’s stock is at … Aptinyx Inc. (NASDAQ:APTX) Shares Plunges -20.41% In A Week – But Can It Keep Rising? Read More »